Hemin: Difference between revisions

Browse history interactively ← Previous edit Next edit →Content deleted Content addedVisual WikitextInline

Revision as of 13:59, 16 May 2011 editLouisajb (talk \| contribs)Extended confirmed users4,402 edits added chembl id← Previous edit		Revision as of 14:12, 16 May 2011 edit undoCheMoBot (talk \| contribs)Bots141,565 edits Updating {{drugbox}} (changes to verified fields - updated 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WiNext edit →
Line 1:		Line 1:
	{{for\|the given name\|Hemin (given name)}}		{{for\|the given name\|Hemin (given name)}}
	{{drugbox		{{drugbox
			\| Verifiedfields = changed
	\| verifiedrevid = 396492199		\| verifiedrevid = 396492199
	\| IUPAC_name = chloroiron(III)		\| IUPAC_name = chloroiron(III)
Line 6:		Line 7:
	\| image2 = Hemin edit1.jpg		\| image2 = Hemin edit1.jpg
	\| CASNo_Ref = {{cascite\|correct\|CAS}}		\| CASNo_Ref = {{cascite\|correct\|CAS}}
			\| ChemSpiderID_Ref = {{chemspidercite\|correct\|chemspider}}
	\| ChemSpiderID = 21160444		\| ChemSpiderID = 21160444
			\| ChEMBL_Ref = {{ebicite\|changed\|EBI}}
	\| ChEMBL = 275704		\| ChEMBL = 275704
	\| UNII_Ref = {{fdacite\|correct\|FDA}}		\| UNII_Ref = {{fdacite\|correct\|FDA}}
Line 12:		Line 15:
	\| InChI = 1/C34H34N4O4.ClH.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);1H;/q;;+3/p-3/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16u;;/rC34H32ClFeN4O4/c1-7-21-17(3)26-14-31-22(8-2)19(5)29-13-25-18(4)23(9-11-33(41)42)28(38-25)16-32-24(10-12-34(43)44)20(6)30(15-27(21)37-26)40(32)36(35)39(29)31/h7-8,13-16H,1-2,9-12H2,3-6H3,(H,41,42)(H,43,44)/b25-13-,26-14-,27-15-,28-16-,29-13-,30-15-,31-14-,32-16u		\| InChI = 1/C34H34N4O4.ClH.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);1H;/q;;+3/p-3/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16u;;/rC34H32ClFeN4O4/c1-7-21-17(3)26-14-31-22(8-2)19(5)29-13-25-18(4)23(9-11-33(41)42)28(38-25)16-32-24(10-12-34(43)44)20(6)30(15-27(21)37-26)40(32)36(35)39(29)31/h7-8,13-16H,1-2,9-12H2,3-6H3,(H,41,42)(H,43,44)/b25-13-,26-14-,27-15-,28-16-,29-13-,30-15-,31-14-,32-16u
	\| InChIKey = BTIJJDXEELBZFS-GASBFGGMBO		\| InChIKey = BTIJJDXEELBZFS-GASBFGGMBO
			\| StdInChI_Ref = {{stdinchicite\|correct\|chemspider}}
	\| StdInChI = 1S/C34H34N4O4.ClH.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);1H;/q;;+3/p-3/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16?;;		\| StdInChI = 1S/C34H34N4O4.ClH.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);1H;/q;;+3/p-3/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16?;;
			\| StdInChIKey_Ref = {{stdinchicite\|correct\|chemspider}}
	\| StdInChIKey = BTIJJDXEELBZFS-UKFHATERSA-K		\| StdInChIKey = BTIJJDXEELBZFS-UKFHATERSA-K
	\| CAS_number = 16009-13-5		\| CAS_number = 16009-13-5

Revision as of 14:12, 16 May 2011

For the given name, see Hemin (given name). Pharmaceutical compound

Hemin
Clinical data


Routes of administration	Intravenous infusion
ATC code	B06AB01 (WHO)
Legal status
Legal status	US: ℞-only
Identifiers
IUPAC name chloroiron(III)
CAS Number	16009-13-5
PubChem CID	5318002
ChemSpider	21160444
UNII	743LRP9S7N
ChEMBL	ChEMBL275704
Chemical and physical data
Formula	C₃₄H₃₂ClFeN₄O₄
Molar mass	651.94 g/mol g·mol
3D model (JSmol)	Interactive image
SMILES OC(=O)CCC=5C1=C\C6=N\C(=C/c3n2(Cl)N1C(=C\C4=N\C(=C/c2c(C=C)c3C)C(/C)=C4/C=C)/C=5C)C(\C)=C6\CCC(O)=O
InChI InChI=1S/C34H34N4O4.ClH.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);1H;/q;;+3/p-3/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16?;; Key:BTIJJDXEELBZFS-UKFHATERSA-K
(what is this?) (verify)

Hemin (trade name Panhematin) is an iron-containing porphyrin. More specifically, it is Protoporphyrin IX containing a ferric iron ion (Heme b) with a chloride ligand.

It is used in the management of porphyria attacks, particularly in acute intermittent porphyria.

It is sometimes distinguished from Hematin which has a hydroxide ligand in place of the chloride. However, the terms are sometimes equated.

Hematin is considered the "X factor" required for the growth of Haemophilus influenzae.

References

"hemin" at Dorland's Medical Dictionary
"hematin" at Dorland's Medical Dictionary
Sherris, John C.; Ryan, Kenneth J.; Ray, C. L. (2004). Sherris medical microbiology: an introduction to infectious diseases. New York: McGraw-Hill. p. 395. ISBN 0-8385-8529-9.{{cite book}}: CS1 maint: multiple names: authors list (link)

External links

Information from the American Porphyria Foundation, including emergency delivery information
Hemin at RxList
Hemin at the U.S. National Library of Medicine Medical Subject Headings (MeSH)

This drug article relating to the blood and blood forming organs is a stub. You can help Misplaced Pages by expanding it.

This biochemistry article is a stub. You can help Misplaced Pages by expanding it.

Categories: